This inventor holds 2 USPTO granted patents. Top assignees: Affymax Technologies, N.v., Affymax, Inc.. Active years: 1998-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2002
Title: Beatrice Ruhland: Innovator in Peptide Technology
Introduction
Beatrice Ruhland is a notable inventor based in Los Altos, CA (US). She has made significant contributions to the field of peptide technology, holding 2 patents that focus on innovative methods for addressing inflammation.
Latest Patents
Her latest patents include "Antagonists of follicle stimulating hormone activity" and "Peptides and compounds that bind selectins including endothelium." The latter patent discloses peptides and peptide mimetics that bind selectins, particularly endothelial leukocyte adhesion molecule 1 (ELAM-1). These peptides are instrumental in blocking the adhesion of leukocytes to selectins, which is crucial for inhibiting inflammation. Additionally, they can be utilized in diagnostic methods that employ labeled peptides to determine the site of inflammation in mammals.
Career Highlights
Throughout her career, Beatrice has worked with prominent companies such as Affymax Technologies, N.V. and Affymax, Inc. Her work has significantly advanced the understanding and application of peptide technology in medical science.
Collaborations
Beatrice has collaborated with esteemed colleagues, including Ronald W. Barrett and Steven E. Cwirla, contributing to her innovative research and development efforts.
Conclusion
Beatrice Ruhland's work in peptide technology exemplifies her commitment to advancing medical science through innovation. Her patents and collaborations highlight her significant impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile